News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
259,182 Results
Type
Article (23392)
Company Profile (104)
Press Release (235686)
Section
Business (69854)
Career Advice (220)
Deals (10348)
Drug Delivery (47)
Drug Development (43540)
Employer Resources (26)
FDA (5671)
Job Trends (5804)
News (127514)
Policy (9982)
Tag
2024 BioCapital Digital (4)
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (3)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (1324)
Academic (1)
Accelerated approval (1)
Adcomms (12)
Allergies (15)
Alliances (20705)
ALS (24)
Alzheimer's disease (459)
Antibody-drug conjugate (ADC) (124)
Approvals (5700)
Artificial intelligence (126)
Autoimmune disease (10)
Automation (3)
Bankruptcy (87)
Best Places to Work (5169)
BIOSECURE Act (2)
Biosimilars (44)
Biotechnology (88)
Bladder cancer (64)
Brain cancer (25)
Breast cancer (272)
Cancer (2112)
Cardiovascular disease (50)
Career advice (201)
Career pathing (8)
CAR-T (127)
Cell therapy (283)
Cervical cancer (21)
Clinical research (35036)
Collaboration (437)
Compensation (136)
Complete response letters (9)
COVID-19 (749)
CRISPR (23)
C-suite (113)
Cystic fibrosis (49)
Data (1095)
Decentralized trials (1)
Denatured (6)
Depression (4)
Diabetes (64)
Diagnostics (3468)
Digital health (6)
Diversity (4)
Diversity, equity & inclusion (6)
Drug discovery (60)
Drug pricing (34)
Drug shortages (3)
Duchenne muscular dystrophy (14)
Earnings (23662)
Editorial (9)
Employer branding (6)
Employer resources (25)
Events (42011)
Executive appointments (302)
FDA (6143)
Featured Employer (18)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (364)
Gene editing (43)
Generative AI (8)
Gene therapy (89)
GLP-1 (201)
Government (1376)
Guidances (14)
Healthcare (7966)
Huntington's disease (2)
IgA nephropathy (7)
Immunology and inflammation (50)
Indications (16)
Infectious disease (791)
Inflammatory bowel disease (55)
Inflation Reduction Act (4)
Influenza (16)
Intellectual property (40)
Interviews (21)
IPO (5408)
IRA (15)
Job creations (903)
Job search strategy (183)
Kidney cancer (10)
Labor market (5)
Layoffs (177)
Leadership (3)
Legal (1680)
Liver cancer (75)
Lung cancer (314)
Lymphoma (128)
Machine learning (1)
Management (9)
Manufacturing (97)
MASH (21)
Medical device (2743)
Medtech (2744)
Mergers & acquisitions (5115)
Metabolic disorders (166)
Multiple sclerosis (9)
NASH (2)
Neurodegenerative disease (19)
Neuropsychiatric disorders (3)
Neuroscience (599)
NextGen: Class of 2025 (2402)
Non-profit (3152)
Northern California (1189)
Now hiring (6)
Obesity (86)
Opinion (85)
Ovarian cancer (75)
Pain (19)
Pancreatic cancer (78)
Parkinson's disease (62)
Partnered (9)
Patents (78)
Patient recruitment (52)
Peanut (10)
People (22137)
Pharmaceutical (22)
Pharmacy benefit managers (4)
Phase I (12753)
Phase II (15213)
Phase III (10736)
Pipeline (546)
Podcasts (25)
Policy (31)
Postmarket research (1146)
Preclinical (5278)
Press Release (27)
Prostate cancer (99)
Psychedelics (6)
Radiopharmaceuticals (235)
Rare diseases (145)
Real estate (1485)
Recruiting (7)
Regulatory (7805)
Reports (15)
Research institute (1475)
Resumes & cover letters (20)
RNA editing (2)
RSV (15)
Schizophrenia (16)
Series A (63)
Series B (34)
Sickle cell disease (20)
Southern California (913)
Special edition (4)
Spinal muscular atrophy (86)
Sponsored (12)
Startups (1457)
State (1)
Stomach cancer (16)
Supply chain (8)
The Weekly (19)
United States (9102)
Vaccines (228)
Venture capitalists (15)
Webinars (2)
Weight loss (43)
Women's health (16)
Worklife (2)
Date
Today (64)
Last 7 days (335)
Last 30 days (1271)
Last 365 days (15225)
2025 (3597)
2024 (15926)
2023 (17900)
2022 (22887)
2021 (23943)
2020 (21276)
2019 (17830)
2018 (13196)
2017 (13036)
2016 (12449)
2015 (14300)
2014 (10506)
2013 (8319)
2012 (8454)
2011 (8829)
2010 (8203)
Location
Africa (223)
Alabama (14)
Alaska (3)
Arizona (48)
Arkansas (3)
Asia (16868)
Australia (3073)
California (2485)
Canada (728)
China (299)
Colorado (97)
Connecticut (120)
Delaware (77)
Europe (36461)
Florida (323)
Georgia (90)
Idaho (17)
Illinois (208)
India (12)
Indiana (129)
Iowa (4)
Japan (64)
Kansas (30)
Kentucky (18)
Maine (7)
Maryland (333)
Massachusetts (1773)
Michigan (41)
Minnesota (105)
Missouri (41)
Montana (17)
Nebraska (10)
Nevada (13)
New Hampshire (40)
New Jersey (794)
New Mexico (12)
New York (799)
North Carolina (312)
North Dakota (3)
Northern California (1189)
Ohio (65)
Oklahoma (3)
Oregon (11)
Pennsylvania (415)
Puerto Rico (3)
Rhode Island (12)
South America (278)
South Carolina (6)
South Dakota (1)
Southern California (913)
Tennessee (15)
Texas (499)
Utah (51)
Virginia (35)
Washington D.C. (17)
Washington State (290)
West Virginia (1)
Wisconsin (32)
259,182 Results for "prostate cancer foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Prostate Cancer Foundation-Funded Research Shows Promising Results Against Lethal Form of Prostate Cancer
A team of investigators at City of Hope funded by the Prostate Cancer Foundation reports that patients with advanced prostate cancer can be safely treated with chimeric antigen receptor T cell therapy.
June 12, 2024
·
4 min read
Prostate cancer
Leaked Conference Article Shows Pfizer’s Positive Phase I Prostate Cancer Data
A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating castration-resistant prostate cancer.
February 11, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Telomir Pharmaceuticals Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model Using Highly Aggressive Human Prostate Cancer Cells
March 19, 2025
·
6 min read
Press Releases
Artera Announces 1st Patient Enrolled in PROSTATE-IQ Trial to Reduce Burden of Hormone Therapy in Men with Prostate Cancer Recurrence After Prostatectomy
March 11, 2025
·
3 min read
Prostate cancer
AstraZeneca’s Truqap Redeems Itself with Phase III Prostate Cancer Win
Truqap’s positive clinical data comes after it failed a late-stage study in metastatic triple-negative breast cancer. It helps AstraZeneca position itself as a top player in the prostate cancer space, alongside its Big Pharma colleagues.
November 26, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Foundation Medicine Awards Grants to Organizations Addressing Disparities in Biomarker Testing for Breast and Prostate Cancer
December 5, 2024
·
3 min read
Press Releases
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
March 21, 2025
·
10 min read
Press Releases
Alberta sets a new standard for advanced prostate cancer treatment with public reimbursement of Pluvicto™
March 10, 2025
·
4 min read
Press Releases
OncoHelix and AstraZeneca Partner to Provide Access to Liquid Biopsy Testing for Men with Prostate Cancer
April 1, 2025
·
3 min read
Approvals
Pfizer Continues Cancer Rally as Adectris Label Expands to Non-Hodgkin Lymphomas
Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate cancer, while recent readouts also position the pharma as a strong contender in colorectal cancer and bladder cancer.
February 13, 2025
·
2 min read
·
Tristan Manalac
1 of 25,919
Next
